![Diwakar Davar and Jason Luke discuss high-risk melanoma from the NADINA trial](https://oncodaily.com/pub/uploads/2024/06/GQ22q_bX0AA9Iqc.jpg)
Photo from ASCO/X
Jun 27, 2024, 15:26
Diwakar Davar and Jason Luke discuss high-risk melanoma from the NADINA trial
The American Society of Clinical Oncology (ASCO) shared on X:
“Diwakar Davar and Jason Luke of UPMC Hillman Cancer Center discuss exciting advances in high-risk melanoma from the NADINA trial and other emerging approaches in immunotherapy from ASCO24 on the ASCO Daily News Podcast.”
Source: ASCO/X
Jul 1, 2024, 19:16